Applications Ligament & Tendon

The current choices for replacement ligament grafts include autologous patellar or hamstring tendons as well as allograft cadaver ligaments.  Autologous procedures are associated with long recovery times and significant harvest site pain while allogenic grafts risk both disease transmission and infection.  With the advent of tissue engineering, an attractive viable graft material may be on the horizon.  However, culturing functional tissue engineered ligament grafts will likely require bioreactors capable of delivering controlled stresses/strains to cell-seeded scaffolds at specified frequencies inside a nutrient rich environment.

The development of successful orthopaedic tissue engineering constructs involves a combination of technologies derived from cell biology, materials science, chemical, electrical and mechanical engineering to produce tissues exhibiting a native state genotype and phenotype with appropriate mechanical and biological properties.

The variety of sensitive needs associated with ligament or tendon growth have triggered several unique and sophisticated process and design strategies in tissue growth.  BISS has adopted specific strategies to address each pertinent application requirement:.

Physiologic Requirements: BISS LigaGen Solutions:
Convective Nutrient Transport: Perfusion Capabilities
Uniform Cell Density: Hydrogel Seeding In Situ
Mechanical Stimulation: Mechanical and Hydrogel grip options
Native Physiological Structure and Function: Biomimetic in vitro Environment

The LigaGen architecture provides a physiologic support system that enhances metabolic conditions for cell growth and maintenance in a 3-D environment.  Physiologic parameters are feedback-controlled for culture reproducibility.  The flexible hardware and computer control systems allow for the development of a wide variety of automated experimental protocols with varying levels of complexity (frequency, force magnitude and application profile) and can accommodate scaffolds up to 150 mm in length.

ABOUT BISS TGT

Did you know that BISS TGT has a wide range of products for Tissue Engineering and Regenerative Medicine (TERM) Applications? Our innovative material testing technology is the most comprehensive commercial solution for the TERM market! We are proud to present BISS TGT TERM.

SERVICE & SUPPORT

OUR CUSTOMERS

  • Children's Mercy Hospital and Clinics
  • Cook Biotech
  • Drexel University
  • FDA Center for Devices and Radiological Health
  • Gel-Del Technologies
See Full List

LATEST NEWS

  • The Challenges of Tissue Characterization
    05.27.2014

    The Challenges of Tissue Characterization TERM research is poised to change the way we know health care. This cutting-edge technology demands new tools and solutions that are able to keep up with the development in personalized medicine. Instron® is delivering those solutions.

    More Info
  • BISS featured in THE HINDU
    07.23.2015

    Bangalore Integrated System Solutions (BISS), a leading test equipment manufacturer, prides in not just ‘making in India’ but also in engaging Indian minds and hands for the same. BISS is a Bengaluru-based developer, manufacturer and exporter of digitally-controlled precision test systems for material and component characterisation in industry, R&D and academia.

    More Info
  • As Featured in Quality Magazine
    10.15.2014

    All parties recognize the importance of developing test standards and providing the est possible medical devices, but determining the best methods is a challenge.

    More Info
  • Instron TERM - Video
    10.01.2014

    See the magic of Instron TERM characterize tissue and culture cells.

    More Info
  • Biomedical Advances
    11.19.2014

    Instron TERM's quarterly newsletter is focused on research and product development challenges in the tissue engineering and regenerative medicine field. Topics include new customer applications, new Instron products, and technology innovation updates.

    More Info
  • Instron TERM sponsors ISACB Webinar Series
    01.08.2015

    Register today for the Winter 2015 Webinar on February 5, 2015. "Stem Cell Therapy for Cardiovascular Disease: From Cell to Heart" Robert Deans, PhD & Keith March, MD, PhD

    More Info
Bangalore Integrated System Solutions (P) ltd.
+91 80 28360184 | tgt@biss.in
Copyright © 2015 - 2017 Bangalore Integrated System Solutions (P) ltd. . All Rights Reserved. BISS aquired Tissue Growth Technologies (TGT)